+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Adult Hemoglobinopathy Testing Market by Modality, Disease Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Adult Hemoglobinopathy Testing Market by Modality, Disease Type, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Adult Hemoglobinopathy Testing Market by Modality, Disease Type, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5887529
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The adult hemoglobinopathy testing market continues to evolve as healthcare systems prioritize precision diagnostics and cost-effective solutions. For senior decision-makers, understanding technology adoption, regulatory challenges, and regional shifts is essential to guide investment and operational strategy.

Market Snapshot: Adult Hemoglobinopathy Testing

The Adult Hemoglobinopathy Testing Market grew from USD 5.10 billion in 2024 to USD 5.41 billion in 2025. It is expected to continue growing at a CAGR of 5.86%, reaching USD 7.18 billion by 2030. This steady expansion reflects rising demand for accurate diagnostics, influenced by aging populations, increasing disease awareness, and technological innovation. Clinical decision-makers are adapting to tighter reimbursement environments alongside greater emphasis on patient outcomes and workflow efficiency.

Scope & Segmentation of the Market

This report delivers actionable insights for leaders across the in vitro diagnostics sector. Market coverage spans the following core segmentation dimensions:

  • Modality: Laboratory-based tests (electrophoresis, genetic analysis, high-performance liquid chromatography) and point-of-care rapid tests.
  • Disease Types: Sickle cell disease, alpha/beta/delta thalassemia, and hemoglobin C disease.
  • End Users: Diagnostic laboratories (hospital labs, independent labs, reference labs), hospitals (secondary and tertiary care), and research institutes.
  • Distribution Channels: Direct sales, distributors (local and regional), and online vendors.
  • Geographies: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, and additional countries), Asia-Pacific (including China, India, Japan, Australia, South Korea, and others).
  • Key Companies: Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Abbott Laboratories, Bio-Rad Laboratories, Inc., Ortho Clinical Diagnostics Inc., Danaher Corporation, Becton, Dickinson and Company, PerkinElmer, Inc., Sysmex Corporation.

Comprehensive sub-segmentation enables in-depth analysis of product types, testing methodologies, care settings, and regional dynamics. Key technologies included are next-generation sequencing, digital pathology platforms, advanced electrophoresis, and integrated AI analytics.

Key Takeaways for Senior Decision-Makers

  • Advancements such as artificial intelligence and next-generation sequencing are streamlining diagnostics, making early and accurate identification feasible across diverse care settings.
  • Strategic collaborations between diagnostics manufacturers, healthcare providers, and academic centers boost innovation pipelines and enable rapid adaptation to shifting clinical guidelines.
  • Point-of-care solutions are expanding market accessibility, allowing for faster turnaround times and improved patient engagement, especially in high-prevalence regions and resource-limited settings.
  • Flexible sourcing and localization of reagent manufacturing are strengthening supply chain resilience in response to volatile international trade requirements and infrastructure gaps.
  • Regional policy differences and varying disease prevalence produce distinct market requirements, presenting partnership opportunities and challenges for global market entrants.

Tariff Impact on Diagnostic Technologies

Recent changes to United States tariffs on imported diagnostic components have introduced additional cost pressures for laboratories and manufacturers. This shift is prompting leaders to explore nearshoring, long-term supply agreements, and domestic production partnerships to safeguard cost efficiency and service continuity. Adapting procurement strategies and supplier relationships is emerging as a critical competitive response to evolving trade policies.

Methodology & Data Sources

The analysis draws on a combination of primary interviews with industry executives, and secondary research from scientific literature, regulatory filings, and proprietary industry databases. Quantitative trends are validated against internal market records and patent filings, while expert panels refine scenario planning and ensure reliability of insights.

Why This Report Matters

  • Supports resource allocation and procurement strategy by mapping evolving diagnostic modalities, care settings, and supply chain dependencies within the adult hemoglobinopathy testing market.
  • Enables evidence-based product development and go-to-market planning through actionable segmentation and regional analysis.
  • Provides clarity on the impact of policy and reimbursement trends to inform pricing, partnership, and compliance priorities.

Conclusion

By providing in-depth coverage of technological innovation, supply chain strategy, and regulatory change, this report facilitates informed, future-proof decisions for leaders navigating the adult hemoglobinopathy diagnostics sector. The insights equip organizations to adapt, collaborate, and seize new growth opportunities in a changing healthcare landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Adult Hemoglobinopathy Testing Market, by Modality
8.1. Introduction
8.2. Laboratory Based Tests
8.2.1. Electrophoresis
8.2.2. Genetic Analysis
8.2.3. High Performance Liquid Chromatography
8.3. Point Of Care Tests
8.3.1. Rapid Tests
9. Adult Hemoglobinopathy Testing Market, by Disease Type
9.1. Introduction
9.2. Hemoglobin C Disease
9.3. Sickle Cell Disease
9.4. Thalassemia
9.4.1. Alpha Thalassemia
9.4.2. Beta Thalassemia
9.4.3. Delta Thalassemia
10. Adult Hemoglobinopathy Testing Market, by End User
10.1. Introduction
10.2. Diagnostic Laboratories
10.2.1. Hospital Laboratories
10.2.2. Independent Laboratories
10.2.3. Reference Laboratories
10.3. Hospitals
10.3.1. Secondary Care Hospitals
10.3.2. Tertiary Care Hospitals
10.4. Research Institutes
11. Adult Hemoglobinopathy Testing Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributors
11.3.1. Local Distributors
11.3.2. Regional Distributors
11.4. Online Vendors
12. Americas Adult Hemoglobinopathy Testing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Adult Hemoglobinopathy Testing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Adult Hemoglobinopathy Testing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Roche Diagnostics International AG
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Siemens Healthineers AG
15.3.4. Abbott Laboratories
15.3.5. Bio-Rad Laboratories, Inc.
15.3.6. Ortho Clinical Diagnostics Inc.
15.3.7. Danaher Corporation
15.3.8. Becton, Dickinson and Company
15.3.9. PerkinElmer, Inc.
15.3.10. Sysmex Corporation
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ADULT HEMOGLOBINOPATHY TESTING MARKET MULTI-CURRENCY
FIGURE 2. ADULT HEMOGLOBINOPATHY TESTING MARKET MULTI-LANGUAGE
FIGURE 3. ADULT HEMOGLOBINOPATHY TESTING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ADULT HEMOGLOBINOPATHY TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ADULT HEMOGLOBINOPATHY TESTING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ADULT HEMOGLOBINOPATHY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY GENETIC ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HIGH PERFORMANCE LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HEMOGLOBIN C DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SICKLE CELL DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ALPHA THALASSEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY BETA THALASSEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DELTA THALASSEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY INDEPENDENT LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REFERENCE LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY SECONDARY CARE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LOCAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY REGIONAL DISTRIBUTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY ONLINE VENDORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 63. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 64. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 65. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 66. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 67. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 68. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 70. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 71. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 72. CANADA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 78. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 80. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 81. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. MEXICO ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 124. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 125. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 126. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 127. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 128. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 129. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 131. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 132. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 133. GERMANY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 134. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 135. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 136. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 137. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 138. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 139. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 141. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 142. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. FRANCE ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 146. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 154. ITALY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 155. ITALY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 156. ITALY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 157. ITALY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 158. ITALY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 159. ITALY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. ITALY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 161. ITALY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 162. ITALY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 163. ITALY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 164. SPAIN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 165. SPAIN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 166. SPAIN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 167. SPAIN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 168. SPAIN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 169. SPAIN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. SPAIN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 171. SPAIN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 172. SPAIN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SPAIN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 174. UNITED ARAB EMIRATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 175. UNITED ARAB EMIRATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 176. UNITED ARAB EMIRATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 184. SAUDI ARABIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 185. SAUDI ARABIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 186. SAUDI ARABIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 194. SOUTH AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 195. SOUTH AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 196. SOUTH AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 204. DENMARK ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 205. DENMARK ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 206. DENMARK ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 207. DENMARK ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 208. DENMARK ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 209. DENMARK ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. DENMARK ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 211. DENMARK ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 212. DENMARK ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 213. DENMARK ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 214. NETHERLANDS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 215. NETHERLANDS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 216. NETHERLANDS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 224. QATAR ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 225. QATAR ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 226. QATAR ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 227. QATAR ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 228. QATAR ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 229. QATAR ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. QATAR ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 231. QATAR ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 232. QATAR ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 233. QATAR ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 234. FINLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 235. FINLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 236. FINLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 237. FINLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 238. FINLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 239. FINLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 240. FINLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 241. FINLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 242. FINLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 243. FINLAND ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 244. SWEDEN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 245. SWEDEN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 246. SWEDEN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 254. NIGERIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 255. NIGERIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 256. NIGERIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 264. EGYPT ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 265. EGYPT ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 266. EGYPT ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 267. EGYPT ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 268. EGYPT ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 269. EGYPT ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 270. EGYPT ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 271. EGYPT ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 272. EGYPT ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. EGYPT ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 274. TURKEY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 275. TURKEY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 276. TURKEY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 277. TURKEY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 278. TURKEY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 279. TURKEY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 280. TURKEY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 281. TURKEY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 282. TURKEY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. TURKEY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 284. ISRAEL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 285. ISRAEL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 286. ISRAEL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTORS, 2018-2030 (USD MILLION)
TABLE 294. NORWAY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
TABLE 295. NORWAY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY LABORATORY BASED TESTS, 2018-2030 (USD MILLION)
TABLE 296. NORWAY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY POINT OF CARE TESTS, 2018-2030 (USD MILLION)
TABLE 297. NORWAY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
TABLE 298. NORWAY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY THALASSEMIA, 2018-2030 (USD MILLION)
TABLE 299. NORWAY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. NORWAY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 301. NORWAY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 302. NORWAY ADULT HEMOGLOBINOPATHY TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 303. NORWAY ADULT HEMOGLOBINOPATHY

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Adult Hemoglobinopathy Testing market report include:
  • Roche Diagnostics International AG
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers AG
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Ortho Clinical Diagnostics Inc.
  • Danaher Corporation
  • Becton, Dickinson and Company
  • PerkinElmer, Inc.
  • Sysmex Corporation

Table Information

Report AttributeDetails
No. of Pages198
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.41 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.18 Billion
Compound Annual Growth Rate5.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Adult Hemoglobinopathy Testing - Global Strategic Business Report - Product Image

Adult Hemoglobinopathy Testing - Global Strategic Business Report

  • Report
  • 174 Pages
  • Global
From
Hemoglobin Testing Market by Test Type, Technology, End User, Distribution Channel, Sample Type - Global Forecast to 2030 - Product Image

Hemoglobin Testing Market by Test Type, Technology, End User, Distribution Channel, Sample Type - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Beta Thalassemia Testing Market by Test Type, Technology, End User, Distribution Channel, Sample Type - Global Forecast to 2030 - Product Image

Beta Thalassemia Testing Market by Test Type, Technology, End User, Distribution Channel, Sample Type - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Dried Blood Spot Collection Cards Market Size, Share & Trends Analysis Report by Application (Newborn Screening, Infectious Disease Testing, Forensics), Card Type (Whatman 903, Ahlstrom 226), End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Dried Blood Spot Collection Cards Market Size, Share & Trends Analysis Report by Application (Newborn Screening, Infectious Disease Testing, Forensics), Card Type (Whatman 903, Ahlstrom 226), End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
D-dimer Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

D-dimer Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.